{"id":188915,"date":"2020-12-11T14:29:48","date_gmt":"2020-12-11T14:29:48","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=188915"},"modified":"2020-12-11T14:29:48","modified_gmt":"2020-12-11T14:29:48","slug":"un-pas-in-spate-in-combaterea-pandemiei-gigantii-farmaceutici-sanofi-si-gsk-amana-lansarea-vaccinului-anti-covid-spre-sfarsitul-anului-viitor","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=188915","title":{"rendered":"Un pas \u00een spate \u00een combaterea pandemiei: Gigan\u0163ii farmaceutici Sanofi \u015fi GSK am\u00e2n\u0103 lansarea vaccinului anti-COVID spre sf\u00e2r\u015fitul anului viitor"},"content":{"rendered":"<p>\nGigan\u0163ii farmaceutici Sanofi \u015fi GlaxoSmithKline (GSK) au declarat c\u0103 ultimele rezultate clinice ale vaccinului anti-COVID-19 pe care \u00eel dezvolt\u0103 au ar\u0103tat un r\u0103spuns imun insuficient \u00een r\u00e2ndul persoanelor v\u00e2rstnice.<\/p>\n<p>\n\u00cen consecin\u0163\u0103, companiile au am\u00e2nat lansarea spre sf\u00e2r\u015fitul anului viitor, marc\u00e2nd un regres un combaterea pandemiei de coronavirus, noteaz\u0103 Reuters.<\/p>\n<p>\nAc\u0163iunile grupului francez Sanofi au sc\u0103zut cu 2,8% \u00een urma anun\u0163ului, \u00een timp ce GSK a \u00eenregistrat un declin de 0,2% pe bursa din Londra. Cele dou\u0103 companii au declarat c\u0103 vor efectua un nou studiu de-a lungul lunii februarie, sper\u00e2nd s\u0103 ob\u0163in\u0103 un vaccin eficient p\u00e2n\u0103 la sf\u00e2r\u015fitul anului viitor.<\/p>\n<p>\nE\u015fecul afecteaz\u0103 una dintre cele mai cunoscute tehnologii de creare a vaccinurilor \u2013 utilizat\u0103 \u00eempotriva virusului Papiloma \u015fi hepatitei B \u2013 care se folose\u015fte de introducerea \u00een corp a proteinelor dezvoltate \u00een laborator pentru a for\u0163a sistemul imunitar s\u0103 produc\u0103 un r\u0103spuns de ap\u0103rare \u00eempotriva virusului SARS-CoV-2.<\/p>\n<p>\nDe asemenea, anun\u0163ul \u00eent\u0103re\u015fte c\u0103utarea unor abord\u0103ri noi, precum cele alese de Pfizer\/BioNTech \u015fi Moderna, care folosesc tehnologia genetic\u0103 mRNA, prin care \u201ep\u0103c\u0103lesc\u201d corpul s\u0103 produc\u0103 aceste proteine. Vaccinurile produse de cele trei companii ofer\u0103 o eficien\u0163\u0103 de aproximativ 95%.<\/p>\n<p>\nDeclara\u0163iile lansate de Sanofi\/GSK contureaz\u0103 provoc\u0103rile cu care se confrunt\u0103 gigan\u0163ii farmaceutici \u00een ceea ce prive\u015fte controlarea pandemiei \u015fi subliniaz\u0103 motivele pentru care \u0163\u0103rile bogate au cump\u0103rat doze pentru a-\u015fi vaccina de trei ori popula\u0163ia \u00een 2021.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gigan\u0163ii farmaceutici Sanofi \u015fi GlaxoSmithKline (GSK) au declarat c\u0103 ultimele rezultate clinice ale vaccinului anti-COVID-19 pe care \u00eel dezvolt\u0103 au ar\u0103tat un r\u0103spuns imun insuficient \u00een r\u00e2ndul persoanelor v\u00e2rstnice. \u00cen consecin\u0163\u0103, companiile au am\u00e2nat lansarea spre sf\u00e2r\u015fitul anului viitor, marc\u00e2nd un regres un combaterea pandemiei de coronavirus, noteaz\u0103 Reuters. Ac\u0163iunile grupului francez Sanofi au sc\u0103zut [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[4551,46034,46210,10805,31061,25486,14930,14848],"class_list":["post-188915","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-amanare","tag-coronavirus","tag-covid","tag-gsk","tag-regres","tag-sanofi","tag-vaccin","tag-vaccinuri"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188915"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188915\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}